Silexion Therapeutics Corp - Ordinary Shares (SLXN) earnings
SLXN earnings moved a median of -3.17% by the close. Quarterly and annual SLXN reports and results, each read against the price at its own news timestamp. Back to the SLXN overview →
12 measured SLXN earnings events.
Where these SLXN earnings landedvs 11 measured SLXN earnings reactions
| Middle 50% of SLXN earnings reactions | -8.17% to +0.29% |
|---|---|
| Median reaction (to close) | -3.17% |
| Measured reactions | 11 |
Point-in-time · zero look-ahead
Half of the 11 SLXN earnings events with a measured close landed between -8.17% and +0.29%; 36% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Silexion Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update | Press release | -2.33% | -22.35% | |
| Form 10-Q Silexion Therapeutics For: Sep 30 | SEC filing · Form 10-Q | -2.33% | -22.35% | |
| Form 10-Q Silexion Therapeutics For: Jun 30 | SEC filing · Form 10-Q | -0.43% | +0.29% | |
| Silexion Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update | Press release | -0.43% | +0.29% | |
| Form 10-K/A Silexion Therapeutics For: Dec 31 | SEC filing · Form 10-K | -4.21% | -12.57% | |
| Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update | Press release | -1.44% | -3.77% | |
| Form 10-Q Silexion Therapeutics For: Mar 31 | SEC filing · Form 10-Q | -1.44% | -3.77% | |
| Form 10-K Silexion Therapeutics For: Dec 31 | SEC filing · Form 10-K | — | -3.17% | |
| Form 10-Q Silexion Therapeutics For: Sep 30 | SEC filing · Form 10-Q | +1.07% | +4.30% | |
| Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update | Press release | +1.07% | +4.30% | |
| Silexion Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update | Press release | +0.46% | — | |
| Silexion Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update | Press release | -2.08% | -1.00% |
Keep exploring
More SLXN: analyst actions → · SEC filings → · SLXN overview →